JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1983; 62:293-297
© 1983 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeevendra Martyn, J. A.
Right arrow Articles by Quinby, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeevendra Martyn, J. A.
Right arrow Articles by Quinby, W. C.

Diazepam Kinetics in Patients with Severe Burns

J. A. Jeevendra Martyn, MD, FFARCS, David J. Greenblatt, MD, and William C. Quinby, MD

Departments of Anesthesia and Surgery, Massachusetts General Hospital and Shriners Burns Institute, and the Departments of Anesthesiology and Surgery, Harvard Medical School, Boston; and the Division of Clinical Pharmacology, Tufts--New England Medical Center, Boston.

Abstract

Because of the increased tolerance of burn patients to sedatives and anesthetic drugs, the effects of severe thermal injury on the pharmacokinetics of diazepam following a single 5– to 10-mg intravenous dose were evaluated in eight patients with burns covering an average of 65% of body surface at a mean of 17 days after injury. Pharmacokinetic parameters were determined from multiple plasma diazepam concentrations measured for 7 days after administration of the diazepam. Eight healthy control subjects, matched with patients for age and sex, were studied identically. The elimination half-life of diazepam was greater, although not significantly so, in burn patients than in control patients (72 and 36 h, respectively). Volume of distribution was also increased in burn patients (2.88 v 1.53 L/kg, P < 0.1), but clearance was comparable in the two groups (0.64 v 0.53 ml/min/kg). However, these results were confounded by a significantly greater free fraction of diazepam in the plasma of burn patients than in control patients (3.43% v 1.24%, P < 0.01). After correction for differences in binding, the volume of distribution of unbound diazepam was comparable between groups (94 v 131 L/kg; not significant), but clearance of free diazepam was significantly reduced in burn patients (24 v 46 ml/min/kg, P < 0.05). If the present data can also be applied to other drugs, then the increased tolerance of patients with burns to sedative and anesthetic drugs cannot be explained on a pharmacokinetic basis but may instead be related to qualitative changes in receptors or in responses of target organs in the central nervous system of burn patients. The reduced clearance of diazepam may be attributable to burn injury and/or concomitant administration of other drugs. Repeated administration of diazepam following burns may result in extraordinary accumulation of drug in the body.

Key Words: PHARMACOKINETICS • diazepam • HYPNOTICS • benzodiazepines, diazepam • COMPLICATIONS: burns







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1983 by the International Anesthesia Research Society.